Bessemer Venture Partners Announces a $1.6 Billion Fund to Invest in the Next Generation of Great Companies

February 2015
Authors: Ed Colloton
Today, Bessemer Venture Partners is pleased to announce a new $1.6 billion fund, BVP IX, to invest in innovative companies around the world.
We are now looking for the next generation of BVP-funded companies.

In addition to exploring exciting new areas of opportunity, we continue to focus on sectors in which we've partnered to build category leaders:
Consumer Internet
Enterprise Technology
Mobile
Cyber Security
Cloud Computing and SaaS
Developer Platforms and Developer Infrastructure
Healthcare IT
Space (our investment in Skybox Imaging—now part of Google—was just the beginning!)

As a firm, BVP invests in companies at all stages. From early investments -Seed/ Series A - in Twilio, Pinterest, Yelp, Skype, and Shopify to growth rounds for LinkedIn and Box, we love to find great teams and support them as they grow. Writing that first check is just the beginning. We continue to support BVP Funded companies through follow-on investments and network relationships, and operational support from experts in business and corporate development, talent acquisition and marketing/communications.

And we make these investments all over the world.

This is an exciting time. In almost every sector of technology, we see disruption as whole categories are reinvented and new categories born. As investors, we are believers in the transformative power of technology. Our mission is to back the world's most talented  entrepreneurs to help them build big businesses and dominate markets.
- See more at: http://www.bvp.com/blog/bessemer-venture-partners-announces-16-billion-fund-invest-next-generation-great-companies#sthash.SXlgZj1Q.dpuf

Suggested Articles

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…

In this week's EuroBiotech Report, Lundbeck inks $2 billion Alder buyout, Euro biotechs raise cash and blast rocks Russian smallpox lab.